Dr. Frederick is a transplant hepatologist with CPMC’s Liver Disease Management and Transplant Program, and he serves as Director of Clinical Protocols and Liver Support Services. He investigates the pathophysiology and treatment of portal hypertension, hepatic encephalopathy, and liver support devices for acute and acute-on-chronic liver failure.
Author of numerous manuscripts, book chapters, and abstracts, Dr. Frederick leads clinical trials of treatments for hepatic encephalopathy, hepatitis B and C, liver failure, and the management of liver transplantation.
Sutter Health Research Enterprise
2340 Clay Street Floor 3
San Francisco, CA, 94115
(916) 732-4380
fredertz@sutterhealth.org
Primary Research Interests
Related Clinical Trials
InFUSE
Terlipressin for HRS-AKI in Liver Transplant Candidates (INFUSE)
Investigators: Todd Frederick M.D., Edward Holt MD, Raphael Merriman MD
Status: Active, Recruiting